BIIB Sentiment Analysis

State of Michigan Retirement System Grows Position in Biogen Inc.

Published on March 15, 2025

State of Michigan Retirement System has increased its position in Biogen Inc....

State of Michigan Retirement System Increases Stake in Biogen Inc.

Published on March 14, 2025

State of Michigan Retirement System has increased its position in Biogen Inc. (NASDAQ:BIIB) by a significant margin....

Biogen Inc. BIIB: A Promising Future in the Pharmaceutical Industry

Published on February 28, 2025

Biogen Inc....

Biogen Inc. BIIB: A Promising Future for the Biotech Giant

Published on February 27, 2025

Biogen Inc., a leading biotech company, is making waves in the stock market with its groundbreaking research and development....

Biogen Inc. BIIB: Innovative Pharmaceutical Stock with Promising Growth Potential

Published on February 26, 2025

Biogen Inc....

Biogen Inc. BIIB: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Published on February 25, 2025

According to analysts at Yahoo Finance, Biogen Inc. (BIIB) is one of the cheap pharmaceutical stocks to buy....

We Think Biogens NASDAQ:BIIB Healthy Earnings Might Be Conservative

Published on February 22, 2025

Biogen Inc. (NASDAQ:BIIB) has recently reported strong earnings, but some believe that these numbers may be conservative....

Biogen Inc Announces Strong EPS Growth in Q4 2024 Earnings Call

Published on February 20, 2025

Biogen Inc, a leading biotechnology company, recently announced strong earnings per share (EPS) growth in its Q4 2024 Earnings Call. Despite facing revenue challenges, the company managed to achieve remarkable growth in EPS, demonstrating its resilie...

Why Biogen Inc. BIIB Is Among the Best Healthcare Stocks To Buy According to Analysts

Published on February 15, 2025

Biogen Inc. (BIIB) has emerged as one of the top healthcare stocks to buy, as recommended by analysts....

Biogen Inc. Continues to Impress with Strong Q4 2024 Earnings

Published on February 14, 2025

Biogen Inc, a leading biotechnology company, reported impressive Q4 2024 earnings, showcasing strong EPS growth despite revenue challenges. The company's earnings call highlighted their commitment to innovation and their ability to navigate through a...

Successful Achievement of Price Target Forecast for Biogen Inc. Yields Profit of 12.88%

Published on February 12, 2025

Biogen Inc. stock recently hit its price target forecast on QuantWave, resulting in a profit of 12....

Biogen Inc. Hits QuantWave's Price Target Forecast, Generating a Profit of 12.75%

Published on February 12, 2025

Biogen Inc. has recently achieved the price target forecast set by QuantWave, resulting in a profit of 12....

QuantWave Achieves 10.46% Profit Target for Biogen Inc. Stock Forecast

Published on February 12, 2025

QuantWave, the automated forecasting platform, has successfully reached its price target for Biogen Inc. stock....

Biogen Inc. BIIB Reports Next Week: Wall Street Expects Earnings Growth

Published on February 10, 2025

As Biogen Inc....

Biogen Inc. Reports Strong Earnings Growth, Analysts Bullish on Stock

Published on February 8, 2025

Biogen Inc., a leading biotechnology company, is set to release its quarterly earnings report next week....

Biogen Inc. Sees Optimistic Outlook as Analysts Share Positive Views

Published on February 4, 2025

Biogen Inc....

Biogen Inc. Receives FDA Approval for LEQEMBI as a Treatment for Early Alzheimer's Disease

Published on January 31, 2025

Biogen Inc., a leading biotechnology company, has announced that its drug LEQEMBI (lecanemab-irmb) has received approval from the U....

FDA Approves LEQEMBI lecanemab-irmb IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease

Published on January 29, 2025

Biogen Inc., a leading biotechnology company, has announced that the U.S....

Sage Therapeutics Rejects Biogen Takeover Bid Explores Strategic Alternatives BIIB Stock News

Published on January 28, 2025

Sage Therapeutics, a leading biopharmaceutical company, recently made headlines as it rejected a takeover bid from Biogen Inc....

Biogen Inc. (NASDAQ: BIIB) Witnesses Unusual Options Activity, Merit Financial Group LLC Acquires Shares

Published on January 26, 2025

Biogen Inc....

Biogen Inc. Receives New Investment from Merit Financial Group LLC

Published on January 25, 2025

Merit Financial Group LLC has made a new investment of $448,000 in Biogen Inc....

Nisa Investment Advisors LLC Purchases 149461 Shares of Biogen Inc. NASDAQ:BIIB

Published on January 24, 2025

Nisa Investment Advisors LLC, a renowned investment firm, has recently made a significant investment in Biogen Inc....

Short Interest in Biogen Inc. NASDAQ:BIIB Increases By 42.6

Published on January 22, 2025

Biogen Inc. (NASDAQ:BIIB), a leading biotechnology company, has witnessed a significant increase in short interest by 42.6%....

Biogen Inc. Stock Hits Price Target Forecast with 10.45% Profit: QuantWave Analysis

Published on January 15, 2025

On December 11, 2024, QuantWave, an automated forecasting platform, issued a short signal for Biogen Inc....

QuantWave Successfully Predicts Biogen Inc. Stock Movement, Generates 9.8% Profit

Published on January 15, 2025

Biogen Inc....